Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study.

Valenciano M, Kissling E, Cohen JM, Oroszi B, Barret AS, Rizzo C, Nunes B, Pitigoi D, Larrauri Cámara A, Mosnier A, Horvath JK, O'Donnell J, Bella A, Guiomar R, Lupulescu E, Savulescu C, Ciancio BC, Kramarz P, Moren A.

PLoS Med. 2011 Jan;8(1):e1000388. doi: 10.1371/journal.pmed.1000388. Epub 2011 Jan 11.

2.

Influenza-like illness in the community during the emergence of 2009 pandemic influenza A(H1N1)--survey of 10 states, April 2009.

Reed C, Angulo FJ, Biggerstaff M, Swerdlow D, Finelli L.

Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S90-3. doi: 10.1093/cid/ciq024.

PMID:
21342906
3.

Surveillance for influenza during the 2009 influenza A (H1N1) pandemic-United States, April 2009-March 2010.

Brammer L, Blanton L, Epperson S, Mustaquim D, Bishop A, Kniss K, Dhara R, Nowell M, Kamimoto L, Finelli L.

Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S27-35. doi: 10.1093/cid/ciq009.

PMID:
21342896
4.

Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010.

Hardelid P, Fleming DM, McMenamin J, Andrews N, Robertson C, SebastianPillai P, Ellis J, Carman W, Wreghitt T, Watson JM, Pebody RG.

Euro Surveill. 2011 Jan 13;16(2). pii: 19763.

5.

Effectiveness of the 2009 seasonal influenza vaccine against pandemic influenza A(H1N1)2009 in healthcare workers in New Zealand, June-August 2009.

Jefferies S, Earl D, Berry N, Blackmore T, Rooker S, Raymond N, Pritchard A, Weatherall M, Beasley R, Perrin K.

Euro Surveill. 2011 Jan 13;16(2). pii: 19761.

6.

Vaccination against the 2009 pandemic influenza A (H1N1) among healthcare workers in the major teaching hospital of Sicily (Italy).

Amodio E, Anastasi G, Marsala MG, Torregrossa MV, Romano N, Firenze A.

Vaccine. 2011 Feb 4;29(7):1408-12. doi: 10.1016/j.vaccine.2010.12.041. Epub 2011 Jan 1.

PMID:
21199700
7.

The public's response to the 2009 H1N1 influenza pandemic.

SteelFisher GK, Blendon RJ, Bekheit MM, Lubell K.

N Engl J Med. 2010 Jun 3;362(22):e65. doi: 10.1056/NEJMp1005102. Epub 2010 May 19. No abstract available.

8.

Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010.

Wichmann O, Stocker P, Poggensee G, Altmann D, Walter D, Hellenbrand W, Krause G, Eckmanns T.

Euro Surveill. 2010 May 6;15(18). pii: 19561.

9.

Influenza A (H1N1) 2009: Impact on Frankfurt in due consideration of health care and public health.

Wicker S, Rabenau HF, Bias H, Groneberg DA, Gottschalk R.

J Occup Med Toxicol. 2010 Apr 26;5:10. doi: 10.1186/1745-6673-5-10.

10.

Which health care workers were most affected during the spring 2009 H1N1 pandemic?

Santos CD, Bristow RB, Vorenkamp JV.

Disaster Med Public Health Prep. 2010 Mar;4(1):47-54.

PMID:
20389195
11.

Low acceptance of vaccination against the 2009 pandemic influenza A(H1N1) among healthcare workers in Greece.

Rachiotis G, Mouchtouri VA, Kremastinou J, Gourgoulianis K, Hadjichristodoulou C.

Euro Surveill. 2010 Feb 11;15(6). pii: 19486.

12.

2009 H1N1 influenza.

Sullivan SJ, Jacobson RM, Dowdle WR, Poland GA.

Mayo Clin Proc. 2010 Jan;85(1):64-76. doi: 10.4065/mcp.2009.0588. Epub 2009 Dec 10. Review.

13.

Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009.

Reed C, Angulo FJ, Swerdlow DL, Lipsitch M, Meltzer MI, Jernigan D, Finelli L.

Emerg Infect Dis. 2009 Dec;15(12):2004-7. doi: 10.3201/eid1512.091413.

14.

The emotional epidemiology of H1N1 influenza vaccination.

Ofri D.

N Engl J Med. 2009 Dec 31;361(27):2594-5. doi: 10.1056/NEJMp0911047. Epub 2009 Nov 25. No abstract available.

15.

New influenza A (H1N1) virus: global epidemiological situation, June 2009.

[No authors listed]

Wkly Epidemiol Rec. 2009 Jun 19;84(25):249-57. English, French. No abstract available.

16.

Evaluation of four real-time PCR assays for detection of influenza A(H1N1)v viruses.

Ellis J, Iturriza M, Allen R, Bermingham A, Brown K, Gray J, Brown D.

Euro Surveill. 2009 Jun 4;14(22). pii: 19230.

17.

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans.

Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V, Okomo-Adhiambo M, Gubareva L, Barnes J, Smith CB, Emery SL, Hillman MJ, Rivailler P, Smagala J, de Graaf M, Burke DF, Fouchier RA, Pappas C, Alpuche-Aranda CM, López-Gatell H, Olivera H, López I, Myers CA, Faix D, Blair PJ, Yu C, Keene KM, Dotson PD Jr, Boxrud D, Sambol AR, Abid SH, St George K, Bannerman T, Moore AL, Stringer DJ, Blevins P, Demmler-Harrison GJ, Ginsberg M, Kriner P, Waterman S, Smole S, Guevara HF, Belongia EA, Clark PA, Beatrice ST, Donis R, Katz J, Finelli L, Bridges CB, Shaw M, Jernigan DB, Uyeki TM, Smith DJ, Klimov AI, Cox NJ.

Science. 2009 Jul 10;325(5937):197-201. doi: 10.1126/science.1176225. Epub 2009 May 22.

18.

Swine influenza A (H1N1) infection in two children--Southern California, March-April 2009.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2009 Apr 24;58(15):400-2.

19.

Influenza vaccination of healthcare workers: a literature review of attitudes and beliefs.

Hofmann F, Ferracin C, Marsh G, Dumas R.

Infection. 2006 Jun;34(3):142-7. Review.

PMID:
16804657
20.

Estimation of vaccine effectiveness using the screening method.

Farrington CP.

Int J Epidemiol. 1993 Aug;22(4):742-6.

PMID:
8225751

Supplemental Content

Support Center